Dossier
Pascal Soriot
Coverage of Pascal Soriot in the Nexus archive.
- AstraZeneca chief warns group could withhold new drugs in Europe
AstraZeneca chief Pascal Soriot warns that the company may withhold new drugs in Europe unless countries increase spending on innovative medicines following a US trade deal.
- AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot stated that AI is accelerating drug development and improving decision-making in research. He highlighted AI's role in increasing the likelihood of success for medicine development.
- AstraZeneca CEO Pascal Soriot delivers remarks as firm celebrates transfer to NYSE
AstraZeneca CEO Pascal Soriot delivered remarks as the company celebrated its transfer to the NYSE. The event marks a significant milestone for the firm's stock market presence.